Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

Project Details

Description

we propose to develop radiolabelled single domain antibodies (sdAbs) as theranostics to identify biomarkers with in vivo molecular imaging in the tumour and its environment.
AcronymBRGRD44
StatusActive
Effective start/end date1/07/2030/06/24

Keywords

  • single domain antibody fragments
  • nuclear imaging
  • targeted radionuclide therapy

Flemish discipline codes in use since 2023

  • Nuclear imaging

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.